Teponi (Tepotinib) 225mg*60 | TLPH Laos Generic | GLT

REQUEST A QUOTE

For individuals and institutions — pricing, availability, and product documents (COA) provided within 24 hours.
Direct line: [email protected] · +86 15234153837

分享
Product description

Generic Information: Teponi (Tepotinib) 225mg — Laos

Teponi is a Lao-manufactured generic of tepotinib, produced by Trans Continental Life Science & Pharmaceuticals (TLPH), a pharmaceutical manufacturer based in Laos. The product is supplied as 225 mg film-coated tablets in 60-tablet bottles, matching the originator's standard strength and pack size. TLPH is among the Lao manufacturers building a portfolio of affordable oncology generics for regional patients who cannot access branded targeted therapies, and Teponi is its tepotinib offering for MET exon 14-mutated NSCLC.

The abbreviation "TLPH" appears on packaging and trade documents, so buyers should recognise both the full company name and the short form when verifying a batch. At the standard 450 mg daily dose — two 225 mg tablets — one bottle of Teponi covers a 30-day month.

What Is Teponi Used For?

Teponi is used for metastatic non-small cell lung cancer carrying the MET exon 14 skipping mutation. This rare driver alteration is identified by molecular testing, and tepotinib is one of the targeted therapies developed specifically for it. Teponi is intended for adults whose disease carries the mutation, including those who have received prior treatment.

How Does Teponi Work?

The tepotinib in Teponi selectively inhibits the MET receptor tyrosine kinase. In tumours with MET exon 14 skipping, the MET receptor is left continuously active because its normal degradation signal is absent, driving unchecked cell growth. Teponi blocks this overactive kinase, slowing tumour progression with a targeted rather than broadly toxic mechanism.

Indications

  • Metastatic non-small cell lung cancer with MET exon 14 skipping mutation, confirmed by a validated test.
  • Adult patients in first-line or later lines of therapy.

Dosage and Administration

Take 450 mg once daily — two 225 mg tablets together — with or without food, swallowed whole. Do not crush or split the tablets. A 60-tablet bottle provides 30 days of therapy. The physician may modify or hold dosing based on oedema, liver function tests or other side effects, and treatment continues while benefit persists.

Side Effects

Common reactions include peripheral oedema, nausea, diarrhoea, fatigue and decreased appetite. Liver enzyme elevations require periodic monitoring. Serious but uncommon risks include interstitial lung disease and QT prolongation; patients should report new breathlessness, cough, palpitations or marked swelling promptly.

Storage

Store Teponi below 30°C in the original bottle, in a dry place, out of the reach of children. Use before the expiry date.

Why Choose the GLT?

GLT verifies each Teponi batch against the manufacturer's documentation and provides a transparent, traceable supply route for Lao generics. Lao-made tepotinib is typically several times cheaper than the branded originator in Western markets, which makes long-term MET-targeted treatment far more affordable for patients and institutions. We provide clear purchase documentation and direct, responsive support throughout ordering and delivery.

How to Order Teponi from GLT

Message GLT on WhatsApp at +86 15234153837 or email [email protected] to order Teponi 225 mg (60 tablets). Tell us your quantity, destination and order type, and we will confirm availability, batch details and shipping terms before dispatch.

FAQ

What does TLPH stand for? TLPH stands for Trans Continental Life Science & Pharmaceuticals, the Lao manufacturer of Teponi.

Is Teponi the same as Tepmetko? Teponi contains the same active ingredient (tepotinib) and dose as Tepmetko, manufactured in Laos by TLPH.

Where can I order Teponi? GLT can supply Teponi internationally; contact us on WhatsApp or email for availability.

Related Oncology Products

SPINRAZA(诺西那生钠)12mg/5mL | 中国购买 | SMA 疗法 | GLT

渤健首创的反义寡核苷酸 SMA 疗法,已获 NMPA 批准并纳入中国国家医保——从 GLT 购买,价格仅为欧美的一小部分。

Tixepa(替尔泊肽)20mg/2mL 和 30mg/2mL 多剂量注射笔 | Drug International | GLT

Tixepa——Drug International Limited (DIL) 替尔泊肽多剂量注射笔,两种官方规格(Tixepa-5=20mg/2mL,Tixepa-7.5=30mg/2mL)用于 2 型糖尿病和肥胖。

Baricent(巴瑞替尼)2mg | 仿制 JAK1/JAK2 抑制剂 | Incepta Pharmaceuticals Ltd. | GLT

由 Incepta Pharmaceuticals Ltd.(孟加拉国)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

Barinib(巴瑞替尼)2mg | 仿制 JAK1/JAK2 抑制剂 | Drug International Limited | GLT

由 Drug International Limited(孟加拉国)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。

Tirzema(替尔泊肽)2.5/5/7.5mg/0.5mL 单剂量注射笔 | Incepta(孟加拉国)| GLT

Tirzema——Incepta Pharmaceuticals 替尔泊肽单剂量注射笔,三种官方规格(2.5/5/7.5mg/0.5mL),用于 2 型糖尿病和体重管理。

Avabopa(阿伐曲泊帕)20mg*30片 | 老挝东盟制药 TLPH | GLT

Avabopa——老挝东盟制药(TLPH)阿伐曲泊帕 20mg,老挝注册号 07 L 0990/23

Barinat(巴瑞替尼)4mg | 仿制 JAK1/JAK2 抑制剂 | Natco Pharma Limited | GLT

由 Natco Pharma Limited(印度)生产的仿制巴瑞替尼(JAK1/JAK2 抑制剂)——用于类风湿关节炎、特应性皮炎和斑秃,是 Olumiant 的平价替代品。